18 citations
,
September 2006 in “Dermatologic Surgery” Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.
4 citations
,
September 2010 in “Medical Hypotheses”
July 2023 in “Journal of allergy and clinical Immunology. Global” A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.
44 citations
,
May 1998 in “PubMed” The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.
January 2007 in “xPharm: The Comprehensive Pharmacology Reference”
133 citations
,
May 2016 in “Cell Host & Microbe” Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.
1 citations
,
January 2005 in “Experimental Dermatology” Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.
Variant G of the KRTAP20-1 gene improves wool curliness in Chinese Tan sheep.
6 citations
,
December 2021 in “Journal of Cancer Research and Therapeutics” The treatment improved survival and controlled cancer spread but required managing side effects like rashes.
7 citations
,
June 2007 in “AIDS” A man's hair loss was linked to his HIV medication, which improved after changing drugs.
September 2025 in “International Journal of Dermatology” 1 citations
,
February 2023 in “Journal of Cosmetic Dermatology” 1 citations
,
July 2021 in “Dermatologic Therapy” 1 citations
,
November 2019 in “Dermatologic Therapy” December 2025 in “Lasers in Surgery and Medicine” February 2025 in “International Journal of Dermatology” February 2025 in “Australasian Journal of Dermatology” October 2022 in “Journal of Cosmetic Dermatology” May 2021 in “FEBS open bio” January 2021 in “Dermatologic Therapy” November 2020 in “Dermatologic Therapy” August 2020 in “International Journal of Dermatology” May 2020 in “Dermatologic Therapy” March 2020 in “Dermatologic Therapy” February 2020 in “Stem Cells Translational Medicine” January 2020 in “Dermatologic Therapy”
October 2018 in “Journal of the European Academy of Dermatology and Venereology” January 2018 in “International Journal of Dermatology” 5 citations
,
April 2024 in “Science China Materials”
4 citations
,
June 2025 in “Medeniyet Medical Journal” TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.